SCHEMBL31163420

SCHEMBL31163420

O=C(NO)c1cc(CCCCN2C=CC3=C(CCC=C3Cl)c3cc(Cl)ccc32)on1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 15/20 0.57
▸ HDAC1 Q13547 9/20 0.54
▸ HDAC3 O15379 4/20 0.37
▸ HDAC2 Q92769 4/20 0.37
▸ HDAC10 Q969S8 3/20 0.37
▸ HDAC4 P56524 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC9 Q9UKV0 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20524102 0.73 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524109 0.70 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524103 0.67 HDAC6 (0.69) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524164 0.67 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524091 0.63 HDAC6 (0.59) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524169 0.61 HDAC6 (0.59) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524131 0.61 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524159 0.60 HDAC6 (0.71) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524059 0.59 HDAC6 (0.78) HDAC6HDAC1HDAC3HDAC2HDAC10
SCHEMBL20524134 0.59 HDAC6 (0.69) HDAC6HDAC1HDAC3HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-04-30 — — US claimed
US-12522572-B2 Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-01-13 — — US claimed
US-20240343697-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2024-10-17 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS HDAC3, HDAC1, HDAC4 HDAC6 10/4885HDAC1 2/4885HDAC3 1/4885
US-20240343697-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS HDAC1, HDAC7, HDAC5 HDAC6 10/4885HDAC1 1/4885HDAC3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback